The Enterprise Value as of December 2024 (TTM) for Opthea Limited (OPT) is 551.97M

According to Opthea Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 551.97M. This represents a change of 589.64% compared to the average of 80.04M of the last 4 quarters.

Opthea Limited (OPT) Historical Enterprise Value (quarterly & annually)

How has OPT Enterprise Value performed in the past?

The mean historical Enterprise Value of Opthea Limited over the last ten years is 149.81M. The current 551.97M Enterprise Value has changed 36.75% with respect to the historical average. Over the past ten years (40 quarters), OPT's Enterprise Value was at its highest in in the December 2019 quarter at 677.21M. The Enterprise Value was at its lowest in in the June 2021 quarter at -118080212.00.

Opthea Limited (OPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Opthea Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opthea Limited (OPT) Average Enterprise Value

How has OPT Enterprise Value performed in the past?

The current Enterprise Value of Opthea Limited (OPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Opthea Limited (OPT) Enterprise Value vs. Peers

How is OPT’s Enterprise Value compared to its peers?

Opthea Limited’s Enterprise Value is greater than Molecular Partners AG (107.67M), greater than MediciNova, Inc. (58.47M), greater than Anebulo Pharmaceuticals, Inc. (38.01M), greater than Champions Oncology, Inc. (117.34M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Aerovate Therapeutics, Inc. (43.78M), greater than Adagene Inc. (13.88M), greater than Acrivon Therapeutics, Inc. Common Stock (148.97M), greater than Rezolute, Inc. (246.61M), greater than AN2 Therapeutics, Inc. (6.83M), greater than Inhibrx Biosciences, Inc. (15.40M), greater than Mineralys Therapeutics, Inc. (527.57M), less than Eliem Therapeutics, Inc. (0),

Build a custom stock screener for Opthea Limited (OPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opthea Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opthea Limited (OPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opthea Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.